A3P's lead product is Stockholm3, a blood test that combines protein markers, genetic markers and clinical data with a proprietary algorithm in order to detect aggressive prostate cancer at an early stage.
Investors 2
| Date | Name | Website |
| 08.05.2022 | Flerie Inv... | flerie.com |
| 20.05.2022 | Stena Sess... | stenasessa... |